APA

Stefanou D., Stamatopoulou S., Sakellaropoulou A., Akakios G., Gkiaouraki M., Gkeka D., Prevezanou M. & Ardavanis A. (2016). Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases. : Oncology letters.

Chicago

Stefanou Dimitra, Stamatopoulou Sofia, Sakellaropoulou Antigoni, Akakios Gavriil, Gkiaouraki Marina, Gkeka Despina, Prevezanou Maria and Ardavanis Alexandros. 2016. Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases. : Oncology letters.

Harvard

Stefanou D., Stamatopoulou S., Sakellaropoulou A., Akakios G., Gkiaouraki M., Gkeka D., Prevezanou M. and Ardavanis A. (2016). Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases. : Oncology letters.

MLA

Stefanou Dimitra, Stamatopoulou Sofia, Sakellaropoulou Antigoni, Akakios Gavriil, Gkiaouraki Marina, Gkeka Despina, Prevezanou Maria and Ardavanis Alexandros. Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases. : Oncology letters. 2016.